Intuitive Surgical, Inc. · NASDAQ (us_market)
Healthcare · Medical Instruments & Supplies · United States
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-06-05$558.06 RISE2025-10-10$429.59 PEAK2026-01-06$592.85 215d | -23.0% 127d | Missed | Missed | — | — | +38.0% 88d | Missed |
DROP2025-01-22$610.45 RISE2025-04-04$451.58 PEAK2025-05-14$565.94 112d | -26.0% 72d | Missed | Missed | — | — | +25.3% 40d | Missed |
DROP2023-07-18$354.93 RISE2023-10-30$258.49 PEAK2024-01-22$375.81 188d | -27.2% 104d | Missed | Missed | — | — | +45.4% 84d | Missed |
DROP2022-12-13$281.74 RISE2023-03-10$224.75 PEAK2023-06-05$317.49 174d | -20.2% 87d | Missed | Missed | — | — | +41.3% 87d | Missed |
DROP2022-08-04$242.46 RISE2022-10-14$183.06 PEAK2022-12-13$281.74 131d | -24.5% 71d | Missed | Missed | — | — | +53.9% 60d | Missed |
DROP2022-04-01$305.54 RISE2022-06-16$190.71 PEAK2022-08-04$242.46 125d | -37.6% 76d | Missed | Missed | — | — | +27.1% 49d | Missed |
DROP2021-12-29$365.27 RISE2022-05-09$208.71 PEAK2022-08-04$242.46 218d | -42.9% 131d | Missed | Missed | — | — | +16.2% 87d | Missed |
DROP2021-11-08$365.42 RISE2022-03-14$263.80 PEAK2022-04-01$305.54 144d | -27.8% 126d | Missed | Missed | — | — | +15.8% 18d | Missed |
DROP2021-11-08$365.42 RISE2022-01-27$262.77 PEAK2022-04-01$305.54 144d | -28.1% 80d | Missed | Missed | — | — | +16.3% 64d | Missed |
DROP2021-01-08$272.92 RISE2021-03-08$228.30 PEAK2021-04-21$297.13 103d | -16.3% 59d | Missed | Missed | — | — | +30.1% 44d | Missed |
DROP2020-09-02$255.04 RISE2020-09-21$213.98 PEAK2020-12-04$260.11 93d | -16.1% 19d | Missed | Missed | — | — | +21.6% 74d | Missed |
DROP2020-02-20$206.10 RISE2020-03-23$122.58 PEAK2020-06-05$197.59 106d | -40.5% 32d | 2020-03-20 $131.40 | 2020-06-05 $197.59 | 83Quality on Sale | 62Deep Value | +61.2% 74d | +50.4% Held 77d |
Intuitive Surgical's stock is in the middle of a deep drawdown, which is actually pretty common for this stock.
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Jensen Huang keeps quoting a $40 trillion humanoid robot TAM, and the market is rewarding every concept video and 2030 roadmap that mentions the word robot. I have been studying physical AI deployments for the better part of two years, and here is what I keep coming back to: the names that survive the inevitable ... 5 Stocks With Real Revenue From Physical AI Today (Not 2030 Promises)
Boston Scientific (BSX) previously commanded a premium valuation based on its transition toward a high-margin cardiovascular powerhouse, driven by its FARAPULSE Pulsed Field Ablation (PFA) system and WATCHMAN cardiac implant. In Q1 2026, the cardiovascular segment posted a strong 13.5% reported growth. However, intense competition from Medtronic (MDT) and Johnson & Johnson (JNJ) has challenged this hyper-growth thesis. Johnson & Johnson's Varipulse system integrates directly into the dominant CA
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best medical technology stocks to buy right now. On May 21, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced a major round of updates to its da Vinci 5 robotic surgical system, including extended instrument use capabilities. The company said more than 100 improvements will roll out to US customers […]
Intuitive Surgical (ISRG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ISRG is widening its robotic surgery lead with faster growth, rising procedures and a recurring revenue model as Medtronic builds Hugo.
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best medical stocks to invest in according to billionaires. Intuitive Surgical, Inc. (NASDAQ:ISRG) announced on May 21 several recent and upcoming innovations, which included enhancements across da Vinci 5 and its supporting ecosystem, advancements designed to enhance product and instrument security and reliability, and extended‑use Force Feedback instruments. Management stated […]
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best medical stocks to invest in according to billionaires. Intuitive Surgical, Inc. (NASDAQ:ISRG) announced on May 21 several recent and upcoming innovations, which included enhancements across da Vinci 5 and its supporting ecosystem, advancements designed to enhance product and instrument security and reliability, and extended‑use Force Feedback instruments. Management stated […]
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best robotic surgery stocks to buy. BofA cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $520 from $650 on May 18, reiterating a Buy rating on the shares. The firm told investors that after having hosted 34 medtech companies the week before in Las Vegas, it […]
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best robotic surgery stocks to buy. BofA cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $520 from $650 on May 18, reiterating a Buy rating on the shares. The firm told investors that after having hosted 34 medtech companies the week before in Las Vegas, it […]
ISRG's Ion platform saw 39% procedure growth in Q1, with new clinical data strengthening its role in lung cancer diagnosis.
ISRG's Ion platform saw 39% procedure growth in Q1, with new clinical data strengthening its role in lung cancer diagnosis.
Over the last six months, Intuitive Surgical’s shares have sunk to $442.32, producing a disappointing 19.9% loss - a stark contrast to the S&P 500’s 13.2% gain. This might have investors contemplating their next move.
Over the last six months, Intuitive Surgical’s shares have sunk to $442.32, producing a disappointing 19.9% loss - a stark contrast to the S&P 500’s 13.2% gain. This might have investors contemplating their next move.
Intuitive Surgical (NasdaqGS:ISRG) has outlined more than 100 new features coming to its da Vinci 5 surgical platform. Key additions include extended-use Force Feedback instruments, security and reliability upgrades, and telepresence tools for remote collaboration. The company expects these updates to broaden the platform’s capabilities in minimally invasive robotic surgery and support surgeon autonomy. For investors watching NasdaqGS:ISRG at a share price of $439.8, this product update...
Intuitive Surgical (NasdaqGS:ISRG) has outlined more than 100 new features coming to its da Vinci 5 surgical platform. Key additions include extended-use Force Feedback instruments, security and reliability upgrades, and telepresence tools for remote collaboration. The company expects these updates to broaden the platform’s capabilities in minimally invasive robotic surgery and support surgeon autonomy. For investors watching NasdaqGS:ISRG at a share price of $439.8, this product update...
While Intuitive Surgical has notably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ISRG | -7.24% | -14.43% | -25.02% | -23.12% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -10.21% | -8.72% | -21.58% | -35.81% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 15.85M | $7.31B | 0.25% | Added+0.9% | 2026-03-31 |
| FidelityFMR | fundamental | 5.48M | $2.52B | 0.13% | Trimmed-16.7% | 2026-03-31 |
| Wellington | fundamental | 3.96M | $1.83B | 0.34% | Added+14.9% | 2026-03-31 |
| TwoSigma | quant | 1.41M | $647.84M | 0.52% | Added+205.6% | 2026-03-31 |
| CapResearch | fundamental | 966.6K | $445.61M | 0.07% | Trimmed-16.9% | 2026-03-31 |
| Coatue | growth | 855.2K | $394.25M | 1.36% | Added+5.9% | 2026-03-31 |
| Citadel | multi-strat | 635.3K | $292.87M | 0.38% | Added+9.0% | 2026-03-31 |
| DEShaw | quant | 576.5K | $265.76M | 0.16% | Trimmed-55.9% | 2026-03-31 |
| RenTech | quant | 139.4K | $64.26M | 0.10% | Trimmed-8.8% | 2026-03-31 |
| ARKK | disruptive | 69.0K | $31.80M | 0.25% | Added+40.5% | 2026-03-31 |
| Bridgewater | macro | 17.3K | $7.97M | 0.04% | Added+54.8% | 2026-03-31 |
| TRowePrice | fundamental | 12.52M | $5.77M | 0.67% | Unchanged | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | Brosius Mark | EVP & Chief Mfg and Supply Cha | S Open-market sale | 18 | $439.80 | −$7.9K |
| 2026-05-22 | Brosius Mark | EVP & Chief Mfg and Supply Cha | S Open-market sale | 18 | $446.04 | −$8.0K |
| 2026-05-20 | Brosius Mark | EVP & Chief Mfg and Supply Cha | S Open-market sale | 18 | $440.38 | −$7.9K |
| 2026-05-20 | Brosius Mark | EVP & Chief Mfg and Supply Cha | S Open-market sale | 18 | $440.70 | −$7.9K |
| 2026-05-20 | Brosius Mark | EVP & Chief Mfg and Supply Cha | S Open-market sale | 18 | $422.47 | −$7.6K |
| 2026-05-11 | LOEB GARY | EVP & Chief Legal and Complian | S Open-market sale | 400 | $446.95 | −$178.8K |
| 2026-05-01 | GUTHART GARY S | Director | A Grant / award(deriv) | 554 | — | +$0 |
| 2026-04-30 | BARRATT CRAIG H | Director | A Grant / award(deriv) | 643 | — | +$0 |
| 2026-04-30 | BARRATT CRAIG H | Director | M Option exercise(deriv) | 750 | — | +$0 |
| 2026-04-30 | BARRATT CRAIG H | Director | M Option exercise | 750 | — | +$0 |
| 2026-04-30 | Beery Joseph C | Director | A Grant / award(deriv) | 554 | — | +$0 |
| 2026-04-30 | Beery Joseph C | Director | M Option exercise(deriv) | 531 | — | +$0 |
| 2026-04-30 | Beery Joseph C | Director | M Option exercise | 531 | — | +$0 |
| 2026-04-30 | CHEW LEWIS | Director | A Grant / award(deriv) | 554 | — | +$0 |
| 2026-04-30 | CHEW LEWIS | Director | M Option exercise(deriv) | 531 | — | +$0 |
| 2026-04-30 | CHEW LEWIS | Director | M Option exercise | 531 | — | +$0 |
| 2026-04-30 | Johnson Amal M | Director | M Option exercise(deriv) | 531 | — | +$0 |
| 2026-04-30 | Johnson Amal M | Director | M Option exercise | 531 | — | +$0 |
| 2026-04-30 | Kolli Sreelakshmi | Director | A Grant / award(deriv) | 554 | — | +$0 |
| 2026-04-30 | Kolli Sreelakshmi | Director | M Option exercise(deriv) | 531 | — | +$0 |
| 2026-04-30 | Kolli Sreelakshmi | Director | M Option exercise | 531 | — | +$0 |
| 2026-04-30 | Ladd Amy L | Director | A Grant / award(deriv) | 554 | — | +$0 |
| 2026-04-30 | Ladd Amy L | Director | M Option exercise(deriv) | 531 | — | +$0 |
| 2026-04-30 | Ladd Amy L | Director | M Option exercise | 531 | — | +$0 |
| 2026-04-30 | Leonard Keith R | Director | A Grant / award(deriv) | 554 | — | +$0 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-21upcoming | 2.50 | — | — |
| 2026-04-21 | 2.11 | 2.50 | +18.67% |
| 2026-01-22 | 1.95 | 2.21 | +13.33% |
| 2025-10-21 | 1.99 | 2.40 | +20.70% |
| 2025-07-22 | 1.61 | 1.81 | +12.42% |
| 2025-04-22 | 1.73 | 1.81 | +4.41% |
| 2025-01-23 | 1.79 | 2.21 | +23.73% |
| 2024-10-17 | 1.64 | 1.84 | +12.25% |
| 2024-07-18 | 1.54 | 1.78 | +15.51% |
| 2024-04-18 | 1.42 | 1.50 | +5.98% |
| 2024-01-23 | 1.49 | 1.60 | +7.72% |
| 2023-10-19 | 1.42 | 1.46 | +3.17% |
| 2023-07-20 | 1.33 | 1.42 | +6.88% |
| 2023-04-18 | 1.20 | 1.23 | +2.83% |
| 2023-01-24 | 1.25 | 1.23 | -1.89% |
| 2022-10-18 | 1.12 | 1.19 | +6.39% |